Murray Dallan sold SRPT
March 4, 2025 · Form 4 insider transaction
Murray Dallan sold 1,685 shares of Sarepta Therapeutics, Inc. at $101.34 per share, a transaction worth $170.8K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,685
Price
$101.34
Total value
$170.8K
InsiderMurray Dallan
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 4, 2025
Filing dateMarch 6, 2025
Shares owned after19,821
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021.